Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ScripsAmerica, a supplier of prescription, over the counter (OTC) and nutraceutical drugs, has signed a two-year manufacturing supply agreement with the manufacturer of its RapiMed children's pain reliever and fever reducer.
Subscribe to our email newsletter
The agreement formalizes the working relationship between ScripsAmerica and RapiMed’s manufacturer.
Both the firms have been working together and just completed ScripsAmerica’s first order ticketed for Hong Kong in the amount of $200,000.
ScripsAmerica CEO Bob Schneiderman said the company’s first RapiMed order took longer to produce since it was contracted for a finished product in the Hong Kong approved packaging which was delivered by its supplier.
"Subsequent orders will be produced in as little as two weeks from the time they are ordered and we anticipate sales of our first product, RapiMed, to increase during the second half of 2014," Schneiderman said.
ScripsAmerica has filed an 8-K with the SEC requesting that disclosing the name of the company’s RapiMed manufacturer be considered as "Disclosure of the Confidential Information" and would seriously harm the company’s competitive advantage in China for its product and ability to secure future manufacturing and supply agreements for RapiMed or other orally disintegrating tablet products on terms more advantageous than the Supply Agreement.